Natus Medical Stock Price, News & Analysis (NASDAQ:BABY)

$28.80 -0.15 (-0.52 %)
(As of 01/16/2018 04:00 PM ET)
Previous Close$28.80
Today's Range$28.25 - $29.25
52-Week Range$28.25 - $43.60
Volume792,399 shs
Average Volume1.16 million shs
Market Capitalization$897.24 million
P/E Ratio-480.00
Dividend YieldN/A
Beta0.84

About Natus Medical (NASDAQ:BABY)

Natus Medical logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:BABY
CUSIP63905010
Phone+1-925-2236700

Debt

Debt-to-Equity Ratio0.36%
Current Ratio4.21%
Quick Ratio3.36%

Price-To-Earnings

Trailing P/E Ratio-480
Forward P/E Ratio17.56
P/E GrowthN/A

Sales & Book Value

Annual Sales$381.89 million
Price / Sales2.35
Cash Flow$2.13 per share
Price / Cash13.55
Book Value$12.68 per share
Price / Book2.27

Profitability

Trailing EPS($0.06)
Net Income$42.59 million
Net Margins-0.62%
Return on Equity12.06%
Return on Assets7.53%

Miscellaneous

Employees1,160
Outstanding Shares31,150,000

Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) posted its quarterly earnings data on Wednesday, October, 25th. The medical equipment provider reported $0.40 EPS for the quarter, beating the Zacks' consensus estimate of $0.38 by $0.02. The medical equipment provider had revenue of $122.60 million for the quarter, compared to analyst estimates of $122.41 million. Natus Medical had a negative net margin of 0.62% and a positive return on equity of 12.06%. The business's revenue for the quarter was up 34.9% on a year-over-year basis. During the same quarter last year, the business earned $0.39 earnings per share. View Natus Medical's Earnings History.

When will Natus Medical make its next earnings announcement?

Natus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for Natus Medical.

What guidance has Natus Medical issued on next quarter's earnings?

Natus Medical updated its fourth quarter earnings guidance on Wednesday, October, 25th. The company provided earnings per share guidance of $0.68-0.72 for the period, compared to the Thomson Reuters consensus estimate of $0.69. The company issued revenue guidance of $145-147 million, compared to the consensus revenue estimate of $141.66 million.

Where is Natus Medical's stock going? Where will Natus Medical's stock price be in 2018?

3 brokers have issued 12 month target prices for Natus Medical's shares. Their forecasts range from $49.00 to $49.00. On average, they expect Natus Medical's share price to reach $49.00 in the next year. View Analyst Ratings for Natus Medical.

Who are some of Natus Medical's key competitors?

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:

  • Robert A. Gunst, Independent Chairman of the Board (Age 67)
  • James B. Hawkins, President, Chief Executive Officer, Director (Age 61)
  • Jonathan A. Kennedy, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 46)
  • Austin F. Noll III, Vice President and General Manager - Neurology Strategic Business Unit (Age 50)
  • D. Christopher Chung M.D., Vice President - Medical Affairs, Quality & Regulatory (Age 53)
  • Doris E. Engibous, Independent Director (Age 62)
  • Kenneth E. Ludlum, Independent Director (Age 62)
  • William M. Moore Jr., Independent Director (Age 66)
  • Barbara R. Paul M.D., Independent Director (Age 63)

Who owns Natus Medical stock?

Natus Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (3.28%), CWM LLC (0.16%) and Bank of Montreal Can (0.15%). Company insiders that own Natus Medical stock include Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Kenneth M Traverso, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical.

Who sold Natus Medical stock? Who is selling Natus Medical stock?

Natus Medical's stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC and CWM LLC. Company insiders that have sold Natus Medical company stock in the last year include Dong Chune Christopher Chung, Doris Engibous, Robert A Gunst and William M Moore. View Insider Buying and Selling for Natus Medical.

Who bought Natus Medical stock? Who is buying Natus Medical stock?

Natus Medical's stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can. View Insider Buying and Selling for Natus Medical.

How do I buy Natus Medical stock?

Shares of Natus Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical's stock price today?

One share of Natus Medical stock can currently be purchased for approximately $28.80.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $897.24 million and generates $381.89 million in revenue each year. The medical equipment provider earns $42.59 million in net income (profit) each year or ($0.06) on an earnings per share basis. Natus Medical employs 1,160 workers across the globe.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 Koll Center Pkwy Ste 120, PLEASANTON, CA 94566-8061, United States. The medical equipment provider can be reached via phone at +1-925-2236700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (BABY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  145 (Vote Outperform)
Underperform Votes:  130 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Natus Medical (NASDAQ:BABY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyHoldHold
Consensus Rating Score: 2.332.502.002.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $49.00$48.00$48.00$47.00
Price Target Upside: 69.26% upside37.14% upside37.14% upside34.29% upside

Natus Medical (NASDAQ:BABY) Consensus Price Target History

Price Target History for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ:BABY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/16/2018BenchmarkLower Price TargetBuy -> Buy$55.00 -> $49.00LowView Rating Details
1/8/2018William BlairDowngradeOutperform -> Market PerformHighView Rating Details
2/2/2017Raymond James FinancialDowngradeOutperform -> Market PerformN/AView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellN/AView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

Natus Medical (NASDAQ:BABY) Earnings History and Estimates Chart

Earnings by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ BABY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018$0.70N/AView Earnings Details
10/25/2017Q3 2017$0.38$0.40$122.41 million$122.60 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.33$0.34$121.99 million$122.20 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.33$0.30$122.45 million$124.70 millionViewN/AView Earnings Details
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.38$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
3/1/2011Q4 2010$0.22$0.24ViewN/AView Earnings Details
10/28/2010Q3 2010$0.19$0.17ViewN/AView Earnings Details
7/29/2010Q2 2010$0.14$0.15ViewN/AView Earnings Details
4/29/2010Q1 2010$0.03$0.09ViewN/AView Earnings Details
3/4/2010Q4 2009$0.15$0.15ViewN/AView Earnings Details
11/2/2009Q3 2009$0.11$0.14ViewN/AView Earnings Details
7/30/2009Q2 2009$0.05$0.08ViewN/AView Earnings Details
4/30/2009Q1 2009$0.03$0.03ViewN/AView Earnings Details
2/26/2009Q4 2008$0.21$0.22ViewN/AView Earnings Details
10/30/2008Q3 2008$0.18$0.17ViewN/AView Earnings Details
7/31/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
5/1/2008Q1 2008$0.10$0.11ViewN/AView Earnings Details
2/26/2008Q4 2007$0.18$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Natus Medical (NASDAQ:BABY) Earnings Estimates

2018 EPS Consensus Estimate: $2.09
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.38$0.38$0.38
Q2 20181$0.49$0.49$0.49
Q3 20181$0.51$0.51$0.51
Q4 20181$0.71$0.71$0.71
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Natus Medical (NASDAQ:BABY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Natus Medical (NASDAQ BABY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 99.87%
Insider Trades by Quarter for Natus Medical (NASDAQ:BABY)
Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ BABY) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/13/2017William M MooreDirectorSell5,000$41.01$205,050.00View SEC Filing  
11/6/2017Dong Chune Christopher ChungVPSell12,642$42.91$542,468.22141,414View SEC Filing  
9/14/2017Robert A GunstDirectorSell4,400$35.17$154,748.0050,850View SEC Filing  
8/14/2017William M MooreDirectorSell3,000$34.10$102,300.0030,410View SEC Filing  
6/15/2017James B HawkinsInsiderBuy4,000$33.98$135,920.00578,023View SEC Filing  
5/31/2017James B. HawkinsInsiderBuy6,000$33.81$202,860.00View SEC Filing  
5/25/2017Doris EngibousDirectorSell5,000$32.68$163,400.0022,650View SEC Filing  
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.0056,150View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00477,396View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00469,725View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.4091,351View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.1891,351View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.0051,150View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00459,725View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.0055,000View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.0018,250View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04112,119View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.5080,325View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00123,043View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99377,274View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.0057,934View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18434,785View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00477,274View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00123,043View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.7674,000View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.4421,910View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.0021,910View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.5421,910View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.0021,910View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00468,844View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42468,844View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30468,844View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24413,844View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.506,000View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04120,972View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20413,211View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Natus Medical (NASDAQ BABY) News Headlines

Source:
DateHeadline
Benchmark Lowers Natus Medical (BABY) Price Target to $49.00Benchmark Lowers Natus Medical (BABY) Price Target to $49.00
www.americanbankingnews.com - January 16 at 12:44 PM
Bear of the Day: Natus Medical (BABY)Bear of the Day: Natus Medical (BABY)
finance.yahoo.com - January 16 at 11:26 AM
Natus Medical (BABY) Downgraded by Zacks Investment ResearchNatus Medical (BABY) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 11 at 7:08 PM
Natus Medical Inc. (BABY) Is Losing Ground On Q1 ForecastNatus Medical Inc. (BABY) Is Losing Ground On Q1 Forecast
www.nasdaq.com - January 8 at 3:45 PM
Why Natus Medical Inc Sank Lower TodayWhy Natus Medical Inc Sank Lower Today
finance.yahoo.com - January 8 at 3:45 PM
Form 8-K NATUS MEDICAL INC For: Jan 08 - StreetInsider.comForm 8-K NATUS MEDICAL INC For: Jan 08 - StreetInsider.com
www.streetinsider.com - January 8 at 8:36 AM
Natus Medical Announces 2018 Annual and First Quarter Financial GuidanceNatus Medical Announces 2018 Annual and First Quarter Financial Guidance
finance.yahoo.com - January 8 at 8:36 AM
$145.85 Million in Sales Expected for Natus Medical Inc (BABY) This Quarter$145.85 Million in Sales Expected for Natus Medical Inc (BABY) This Quarter
www.americanbankingnews.com - January 7 at 6:26 PM
Natus Medical (BABY) Stock Rating Lowered by BidaskClubNatus Medical (BABY) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - January 6 at 8:10 PM
Natus Medical (BABY) Shares Cross Below 200 DMANatus Medical (BABY) Shares Cross Below 200 DMA
www.nasdaq.com - January 4 at 11:12 AM
Natus Medical (BABY) Downgraded by Zacks Investment Research to HoldNatus Medical (BABY) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - December 26 at 10:36 PM
ETFs with exposure to Natus Medical, Inc. : December 26, 2017ETFs with exposure to Natus Medical, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 12:39 PM
Natus Medical Inc (BABY) Receives Average Rating of "Hold" from AnalystsNatus Medical Inc (BABY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 26 at 12:06 AM
Natus Medical, Inc. :BABY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017Natus Medical, Inc. :BABY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:19 PM
Natus Medical Inc (BABY) Expected to Announce Quarterly Sales of $145.85 MillionNatus Medical Inc (BABY) Expected to Announce Quarterly Sales of $145.85 Million
www.americanbankingnews.com - December 21 at 2:02 PM
Natus Medical Shows Improved Relative Strength; Still Shy Of BenchmarkNatus Medical Shows Improved Relative Strength; Still Shy Of Benchmark
finance.yahoo.com - December 20 at 11:26 AM
Natus Medical, Inc. is trading above its 50 day moving average : BABY-US : December 20, 2017Natus Medical, Inc. is trading above its 50 day moving average : BABY-US : December 20, 2017
finance.yahoo.com - December 20 at 11:26 AM
4 Growth Stocks to Pick From a Choppy MedTech Market - Nasdaq4 Growth Stocks to Pick From a Choppy MedTech Market - Nasdaq
www.nasdaq.com - December 14 at 11:33 AM
4 Growth Stocks to Pick From a Choppy MedTech Market4 Growth Stocks to Pick From a Choppy MedTech Market
finance.yahoo.com - December 14 at 11:33 AM
Natus to Present at J.P. Morgan 36th Annual Healthcare Conference ... - GlobeNewswire (press release)Natus to Present at J.P. Morgan 36th Annual Healthcare Conference ... - GlobeNewswire (press release)
globenewswire.com - December 13 at 3:42 PM
Natus to Present at J.P. Morgan 36th Annual Healthcare ConferenceNatus to Present at J.P. Morgan 36th Annual Healthcare Conference
finance.yahoo.com - December 13 at 11:44 AM
Natus Medical (BABY) Downgraded by BidaskClub to "Sell"Natus Medical (BABY) Downgraded by BidaskClub to "Sell"
www.americanbankingnews.com - December 9 at 10:36 AM
 Brokerages Expect Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 Million Brokerages Expect Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 Million
www.americanbankingnews.com - December 3 at 6:26 AM
Stocks With Rising Relative Strength: Natus MedicalStocks With Rising Relative Strength: Natus Medical
finance.yahoo.com - December 1 at 6:31 PM
Natus Medical Incorporated (BABY) Given Average Rating of "Hold" by AnalystsNatus Medical Incorporated (BABY) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 30 at 11:48 PM
Earnings Review and Free Research Report: Natus Medical’s Revenue Soared 34.9%Earnings Review and Free Research Report: Natus Medical’s Revenue Soared 34.9%
finance.yahoo.com - November 22 at 5:02 PM
Natus Medical, Inc. – Value Analysis (NASDAQ:BABY) : November 17, 2017Natus Medical, Inc. – Value Analysis (NASDAQ:BABY) : November 17, 2017
finance.yahoo.com - November 17 at 4:03 PM
Natus Medical (BABY) Presents At Stifel 2017 Healthcare Conference - SlideshowNatus Medical (BABY) Presents At Stifel 2017 Healthcare Conference - Slideshow
seekingalpha.com - November 16 at 4:37 PM
Natus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : November 16, 2017Natus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : November 16, 2017
finance.yahoo.com - November 16 at 9:04 AM
Natus Medical Incorporated (BABY) Director William M. Moore Sells 5,000 SharesNatus Medical Incorporated (BABY) Director William M. Moore Sells 5,000 Shares
www.americanbankingnews.com - November 15 at 8:44 PM
Zacks.com highlights: Natus Medical, GoPro, Enviva Partners and BrukerZacks.com highlights: Natus Medical, GoPro, Enviva Partners and Bruker
finance.yahoo.com - November 15 at 3:17 PM
4 Top Stocks With Earnings Acceleration to Buy Now4 Top Stocks With Earnings Acceleration to Buy Now
finance.yahoo.com - November 14 at 4:46 PM
Zacks: Analysts Anticipate Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 MillionZacks: Analysts Anticipate Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 Million
www.americanbankingnews.com - November 14 at 3:56 AM
 Brokerages Anticipate Natus Medical Incorporated (BABY) Will Post Earnings of $0.71 Per Share Brokerages Anticipate Natus Medical Incorporated (BABY) Will Post Earnings of $0.71 Per Share
www.americanbankingnews.com - November 12 at 10:04 PM
Natus to Present at 29th Annual Piper Jaffray Healthcare ConferenceNatus to Present at 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 9 at 3:42 PM
Insider Selling: Natus Medical Incorporated (BABY) VP Sells 12,642 Shares of StockInsider Selling: Natus Medical Incorporated (BABY) VP Sells 12,642 Shares of Stock
www.americanbankingnews.com - November 8 at 6:48 PM
Stocks To Watch: Natus Medical Sees Relative Strength Rating Rise To 84Stocks To Watch: Natus Medical Sees Relative Strength Rating Rise To 84
finance.yahoo.com - November 8 at 6:44 PM
Head to Head Analysis: Natus Medical (BABY) versus Its CompetitorsHead to Head Analysis: Natus Medical (BABY) versus Its Competitors
www.americanbankingnews.com - November 2 at 5:30 PM
Natus Medical Shows Rising Relative Strength; Still Shy Of Key BenchmarkNatus Medical Shows Rising Relative Strength; Still Shy Of Key Benchmark
finance.yahoo.com - October 31 at 5:31 PM
Natus Medical Incorporated Forecasted to Earn FY2017 Earnings of $1.74 Per Share (BABY)Natus Medical Incorporated Forecasted to Earn FY2017 Earnings of $1.74 Per Share (BABY)
www.americanbankingnews.com - October 27 at 9:32 AM
Oh Baby! Natus Medical Inc. Beats and Raises GuidanceOh Baby! Natus Medical Inc. Beats and Raises Guidance
finance.yahoo.com - October 26 at 4:21 PM
Edited Transcript of BABY earnings conference call or presentation 25-Oct-17 3:00pm GMTEdited Transcript of BABY earnings conference call or presentation 25-Oct-17 3:00pm GMT
finance.yahoo.com - October 26 at 9:41 AM
Natus to Present at Stifel 2017 Healthcare ConferenceNatus to Present at Stifel 2017 Healthcare Conference
finance.yahoo.com - October 26 at 9:40 AM
Critical Review: Natus Medical (BABY) and Its CompetitorsCritical Review: Natus Medical (BABY) and Its Competitors
www.americanbankingnews.com - October 26 at 1:16 AM
Critical Survey: Natus Medical (BABY) versus Hansen Medical (HNSN)Critical Survey: Natus Medical (BABY) versus Hansen Medical (HNSN)
www.americanbankingnews.com - October 25 at 7:10 PM
Natus Medical Announces Third Quarter 2017 Financial Results - GlobeNewswire (press release)Natus Medical Announces Third Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - October 25 at 5:39 PM
Natus Medical Announces Third Quarter 2017 Financial ResultsNatus Medical Announces Third Quarter 2017 Financial Results
finance.yahoo.com - October 25 at 5:39 PM
Natus Medical reports 3Q lossNatus Medical reports 3Q loss
finance.yahoo.com - October 25 at 5:39 PM
Reviewing BIOLASE (BLTI) and Natus Medical (BABY)Reviewing BIOLASE (BLTI) and Natus Medical (BABY)
www.americanbankingnews.com - October 25 at 3:42 PM
Natus Medical Incorporated (BABY) Announces Quarterly  Earnings ResultsNatus Medical Incorporated (BABY) Announces Quarterly Earnings Results
www.americanbankingnews.com - October 25 at 11:13 AM

SEC Filings

Natus Medical (NASDAQ:BABY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Natus Medical (NASDAQ:BABY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Natus Medical (NASDAQ BABY) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.